logo

Stock Screener

Forex Screener

Crypto Screener

DCGO

DocGo Inc. (DCGO)

$

2.64


Key metrics

Financial statements

Free cash flow per share

Free cash flow per share

0.6299

Market cap

Market cap

269.2 Million

Price to sales ratio

Price to sales ratio

0.4367

Debt to equity

Debt to equity

0.1782

Current ratio

Current ratio

2.4998

Income quality

Income quality

5.2645

Average inventory

Average inventory

0

ROE

ROE

0.0000



Technology

Technology

Technology – consumer electronics

Largecap

Largecap

With a market cap of 121,78 bil stock is ranked 1

Low risk

Low risk

ISS score of this stock is ranked 1


Company description

Profile

DocGo, Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company recorded an operating income of $28,688,726,000,000.00 reflecting its earnings from core operations. The gross profit stands at $213,574,575.00 highlighting the company's profitability from core operations. Furthermore, the gross profit ratio is 0.35 which reflects the efficiency of the company's production and sales operations. The net income ratio is 0.03 signifying the company's profitability margin. Additionally, the company incurred an income tax expense of -$14,388,422,000,000.00 indicating its tax obligations. Its transportation services include emergency response services as well as non-emergency transport options like ambulance and wheelchair transportation. Alongside these services, DocGo, Inc. offers mobile health services that are performed at home and in offices, COVID-19 testing, and event services providing on-site healthcare support at various events such as sporting matches and concerts. This dynamic range of services showcases the company's commitment to healthcare solutions. Established in 2015, DocGo, Inc. is headquartered in New York, New York. The stock is affordable at $2.61 making it suitable for budget-conscious investors. With a market capitalization of $269,235,120.00 the company is classified as a small-cap player, allowing for growth potential within its market segment. The stock has an average trading volume of 804,785.00 indicating moderate liquidity and facilitating easier trades for investors. It is a key player in the Medical - Care Facilities industry, contributing significantly to the overall market landscape. By belonging to the Healthcare sector, DocGo, Inc. drives innovation and growth, providing essential services that meet the evolving needs of healthcare. This strategic positioning enhances its visibility and competitiveness in the market, reflecting the company’s efforts toward expanding its influence and reach within the healthcare sector.

What is DocGo Inc. (DCGO)'s current stock price?

The current stock price of DocGo Inc. (DCGO) is $2.68 as of 2025-04-01. Prices may fluctuate during the trading day. For real-time updates, check your brokerage platform or financial news websites.

Analysts predict DocGo Inc. stock to fluctuate between $2.51 (low) and $5.68 (high) in the next 365 days, reflecting market expectations and potential volatility.

As of 2025-04-01, DocGo Inc.'s market cap is $269,235,120, based on 101,983,000 outstanding shares.

Compared to Meta Platforms, Inc. Class A Common Stock, DocGo Inc. has a Lower Market-Cap, indicating a difference in performance.

To buy DocGo Inc. (DCGO) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for DCGO. Place an order (Market, Limit, etc.).

The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.

Revenue: $616,555,132 | EPS: $0.20 | Growth: 201.66%.

Visit https://www.docgo.com/investor-relations for detailed financial reports.

You can explore historical data from here

All-time high: $11.41 (2022-10-11) | All-time low: $2.51 (2025-03-31).

Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.


News

DCGO

businesswire.com

DocGo Earns Great Place To Work Certification™ For the Third Time in a Row

NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced that it has been Certified™ by Great Place To Work® for the third time in a row. This prestigious award is based on what current employees say about their experience working at the Company. This year, employees rated DocGo 31% higher than the average US company as a Great Place to Work. Great Place To Work® is the global authority on w.

DCGO

businesswire.com

DocGo Announces Upcoming Participation at Needham Virtual Healthcare Conference

NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health services, today announced that Lee Bienstock, Chief Executive Officer, will participate in a fireside chat at the Needham Virtual Healthcare Conference on Monday, April 7th at 11:45 AM Eastern Time, and hold virtual 1x1 meetings as well. A webcast of the event will be available on the investor relations section of DocGo's website at https://ir.docgo.com/. About DocGo DocGo is l.

DCGO

seekingalpha.com

DocGo: I'm Still On The Fence On This One

DocGo's shares have plummeted over 45% since mid-February, declining over 20% after reporting Q4 '24 on February 27th. The company has relied on contingencies such as COVID-19 testing and large contracts for a significant part of its revenues, much of which has now dried up. The company is transitioning to a new revenue model targeting Health Insurance Partnerships, aiming for more stable and predictable revenues. Yet, this space is highly competitive.

DCGO

seekingalpha.com

DocGo, Inc (DCGO) Q4 2024 Earnings Call Transcript

DocGo, Inc (NASDAQ:DCGO ) Q4 2024 Results Conference Call February 27, 2025 5:00 PM ET Company Participants Mike Cole - VP of Investor Relations Lee Bienstock - Chief Executive Officer Norman Rosenberg - Chief Financial Officer Conference Call Participants Pito Chickering - Deutsche Bank Richard Close - Canaccord Genuity David Larsen - BTIG Aidan Conniff - Stifel Operator Good afternoon, ladies and gentlemen, and welcome to the DocGo Fourth Quarter and Full Year 2024 Earnings Call. At this time, all lines are in listen only mode.

DCGO

zacks.com

DocGo Inc. (DCGO) Q4 Earnings Beat Estimates

DocGo Inc. (DCGO) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.06 per share a year ago.

DCGO

businesswire.com

DocGo Expands into Chattanooga Region in Collaboration with Major Tennessee Healthcare System

NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced that its Ambulnz subsidiary has extended its contract with a major Tennessee healthcare system to launch services in Chattanooga, TN. This expansion highlights the Company's expertise in delivering reliable and efficient advanced medical transportation services for its partners. Ambulnz by DocGo will provide vital services in the Chatt.

DCGO

businesswire.com

DocGo Announces Upcoming Participation at TD Cowen 45th Annual Health Care Conference

NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health services, announced today that Lee Bienstock, Chief Executive Officer, will participate in 1x1 meetings at the TD Cowen 45th Annual Health Care Conference on Wednesday March 5th, and will deliver a presentation at 11:10 – 11:40 AM ET on that day. A webcast of the event will be available on the investor relations section of DocGo's website at https://ir.docgo.com/. About DocGo D.

DCGO

businesswire.com

DocGo to Announce Fourth Quarter and Full Year 2024 Results on Thursday, February 27, 2025

NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, announced today that the Company will release its financial results for the fourth quarter and full year ended December 31, 2024 after the markets close on Thursday, February 27, 2025. Management will also host a conference call to discuss these results at 5:00 p.m. ET on that day. Conference call and webcast details: Thursday, February 27, 2025 5:00.

See all news

logo
Stocks, Indicators, Pattern screeners all at one place
Stock Screener
Forex Screener
Crypto Screener